Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 22, 2005. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding the GlaxoSmithKline Annual Investment Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification of share transactions rather than a financial performance report.
Material Changes
The filing details an increase in share interests for Mrs. J Younger following the distribution of shares on August 11, 2005. This distribution resulted from the maturity of the 2002 election under the GlaxoSmithKline Annual Investment Plan. The specific increase recorded was 3,486 Ordinary Shares.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to the disclosure of the specific share transaction in accordance with Disclosure Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Transaction Date: August 11, 2005 (distribution); August 19, 2005 (notification).
- Individual Involved: Mrs. J Younger.
- Share Increase: 3,486 Ordinary Shares.
- Source of Shares: Maturity of the 2002 election under the GlaxoSmithKline Annual Investment Plan.
- Regulatory Basis: Disclosure Rule 3.1.4R(1)(a).